Infliximab in paediatric inflammatory bowel disease

被引：9

作者：

Vilar, Pere ^{[1
]}

Martin de Carpi, Javier ^{[1
]}

Acuna, Claudia E. ^{[2
]}

Luisa Masiques, Ma ^{[3
]}

机构：

[1] Hosp Univ St Joan Deu, Paediat Gastroenterol Sect, Barcelona 08950, Spain

[2] Hosp Gen Cataluna, Dept Paediat, Paediat Gastroenterol Unit, Barcelona, Spain

[3] Hosp Gen Granollers, Dept Paediat, Paediat Gastroenterol Unit, Barcelona, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2007年 / 1卷 / 01期

关键词：

Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Children; Infliximab; Growth;

D O I：

10.1016/j.crohns.2007.07.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Infliximab has been widely used in paediatric Crohn's disease, mainly in luminal and fistulous disease refractory to standard treatment and for extraintestinal manifestations. Moreover, there is growing experience with its use in refractory ulcerative colitis. Infliximab has shown similar efficacy and safety in children as in adult population. It is postulated that its early use in paediatric inflammatory bowel disease, as a bridging treatment until the onset of action of other immunomodulators, could reduce the use of steroids and change the natural history of the disease as well. The effect of infliximab on mucosal heating could also contribute to the normal growth and sexual maturation in these patients. (C) 2007 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

引用

页码：2 / 9

页数：8

共 60 条

[1] Cardiac involvement in children with IBD during infliximab therapy [J].

Barbato, Maria ;

Curione, Mario ;

Viola, Franca ;

Parisi, Fabiana ;

Amato, Silvia ;

Cucchiara, Salvatore .

INFLAMMATORY BOWEL DISEASES, 2006, 12 (08) :828-829

[2] Gastrointestinal inflammation and the circulating IGF system in humans [J].

Baricevic, I ;

Jones, DR ;

Nikolic, JA ;

Nedic, O .

HORMONE AND METABOLIC RESEARCH, 2006, 38 (01) :22-27

[3]

BASCIETTO C, 2005, J PEDIAT GASTROENTER, V40

[4] Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease [J].

Borrelli, O ;

Bascietto, C ;

Viola, F ;

de Mesquita, MB ;

Barbato, M ;

Mancini, V ;

Bosco, S ;

Cucchiara, S .

DIGESTIVE AND LIVER DISEASE, 2004, 36 (05) :342-347

[5] GROWTH AND PUBERTY IN CHRONIC INFLAMMATORY BOWEL-DISEASE [J].

BRAIN, CE ;

SAVAGE, MO .

BAILLIERES CLINICAL GASTROENTEROLOGY, 1994, 8 (01) :83-100

[6] Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease [J].

Canani, R. Berni ;

Terrin, G. ;

Borrelli, O. ;

Romano, M. T. ;

Manguso, F. ;

Coruzzo, A. ;

D'Armiento, F. ;

Romeo, E. F. ;

Cucchiara, S. .

DIGESTIVE AND LIVER DISEASE, 2006, 38 (06) :381-387

[7] European evidence based consensus on the diagnosis and management of Crohn's disease: special situations [J].

Caprilli, R ;

Gassull, MA ;

Escher, JC ;

Moser, G ;

Munkholm, P ;

Forbes, A ;

Hommes, DW ;

Lochs, H ;

Angelucci, E ;

Cocco, A ;

Vucelic, B ;

Hildebrand, H ;

Kolacek, S ;

Riis, L ;

Lukas, M ;

de Franchis, R ;

Hamilton, M ;

Jantschek, G ;

Michetti, P ;

O'Morain, C ;

Anwar, MM ;

Freitas, JL ;

Mouzas, IA ;

Baert, F ;

Mitchel, R ;

Hawkey, CJ .

GUT, 2006, 55 :i36-i58

[8] The incidence and management of infusion reactions to infliximab: A large center experience [J].

Cheifetz, A ;

Smedley, M ;

Martin, S ;

Reiter, M ;

Leone, G ;

Mayer, L ;

Plevy, S .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) :1315-1324

[9] Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease [J].

Corken Mackey, Ann ;

Green, Lanh ;

Liang, Li-ching ;

Dinndorf, Patricia ;

Avigan, Mark .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (02) :265-267

[10] The insulin-like growth factor axis in children with inflammatory bowel disease [J].

Corkins, MR ;

Gohil, AD ;

Fitzgerald, JF .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 36 (02) :228-234

← 1 2 3 4 5 6 →